Physician profile
Catherine W Gardner
NPI 1730270463
$12,065.97
in general payments reported to CMS, 2019-2025
29 companies · $8,428 in 2025
The $8,428 reported for 2025 was more than what 99% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,086 · 2022: $1,150 · 2023: $597 · 2024: $805 · 2025: $8,428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,873 · Food and Beverage: $1,957.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,872.65 |
| Food and Beverage | $1,956.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $8,484.56 | 2021-2025 | Nexplanon |
| Astrazeneca Pharmaceuticals Lp | $589.98 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $455.49 | 2021-2023 | |
| Daiichi Sankyo INC. | $360.86 | 2021-2022 | |
| Abbott Laboratories | $322.44 | 2021-2023 | Freestyle Libre 3 |
| Agile Therapeutics, INC. | $255.64 | 2021-2024 | Twirla |
| Otsuka America Pharmaceutical, INC. | $173.05 | 2022 | |
| Abbvie INC. | $149.97 | 2021-2023 | |
| Actelion Pharmaceuticals US, INC. | $137.13 | 2024 | Opsumit, Uptravi |
| Esperion Therapeutics, INC. | $124.99 | 2021 | |
| Eisai INC. | $123.13 | 2021 | |
| Phathom Pharmaceuticals, INC. | $123.12 | 2024 | Voquezna |
| Novo Nordisk INC | $116.01 | 2022 | |
| Althera Pharmaceuticals LLC | $105.00 | 2022 | |
| Exact Sciences Corporation | $77.13 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $75.69 | 2022-2023 | Balcoltra |
| Merck Sharp & Dohme LLC | $63.11 | 2021-2022 | |
| Sage Therapeutics, LLC | $52.05 | 2025 | Zurzuvae |
| Amarin Pharma, INC. | $43.44 | 2021-2022 | |
| Pfizer INC. | $39.90 | 2022-2023 | |
| Mayne Pharma Commercial LLC | $36.45 | 2025 | |
| Therapeuticsmd, INC. | $32.64 | 2022 | |
| Millicent US INC | $26.24 | 2021-2024 | Intrarosa, Femring |
| Alexion Pharmaceuticals, INC. | $24.93 | 2023 | Ultomiris |
| Bayer Healthcare Pharmaceuticals INC. | $17.55 | 2023 | |
| Minerva Surgical, INC | $15.05 | 2023 | |
| Hologic Sales and Service, LLC | $14.39 | 2025 | Thinprep 2000 Processor, Aptima |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.31 | 2022 | |
| Lilly USA, LLC | $12.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.